Overview
Terazosin is a quinazoline derivative alpha-1-selective adrenergic blocking agent indicated for benign prostatic hyperplasia and hypertension. Terazosin blocks adrenaline's action on alpha-1 adrenergic receptors, causing relaxation of smooth muscle in blood vessels and the prostate.
Background
Terazosin is a quinazoline derivative alpha-1-selective adrenergic blocking agent indicated for benign prostatic hyperplasia and hypertension. Terazosin blocks adrenaline's action on alpha-1 adrenergic receptors, causing relaxation of smooth muscle in blood vessels and the prostate.
Indication
Terazosin is indicated for use in treating symptomatic benign prostatic hyperplasia and hypertension.
Associated Conditions
- Benign Prostatic Hyperplasia (BPH)
- Hypertension
- Ureteral Calculus
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/05/13 | Phase 3 | Not yet recruiting | Penang Hospital, Malaysia | ||
2023/05/11 | Phase 4 | Not yet recruiting | I.R.C.C.S. Fondazione Santa Lucia | ||
2021/11/05 | Phase 2 | Recruiting | |||
2021/02/18 | Phase 1 | Not yet recruiting | Qiang Zhang | ||
2020/09/16 | Phase 1 | Active, not recruiting | |||
2020/05/13 | Phase 2 | Recruiting | |||
2019/04/05 | Phase 1 | Completed | |||
2017/06/22 | Phase 2 | UNKNOWN | Capital Medical University | ||
2012/02/09 | Phase 2 | Completed | |||
2012/01/12 | Not Applicable | UNKNOWN |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Golden State Medical Supply, Inc. | 51407-734 | ORAL | 5 mg in 1 1 | 8/8/2023 | |
| REMEDYREPACK INC. | 70518-0342 | ORAL | 1 mg in 1 1 | 5/28/2025 | |
| Bryant Ranch Prepack | 63629-2439 | ORAL | 10 mg in 1 1 | 12/7/2017 | |
| Aphena Pharma Solutions - Tennessee, LLC | 71610-762 | ORAL | 10 mg in 1 1 | 12/15/2023 | |
| Chartwell RX, LLC | 62135-459 | ORAL | 2 mg in 1 1 | 2/9/2023 | |
| AvPAK | 50268-766 | ORAL | 5 mg in 1 1 | 5/6/2022 | |
| Bryant Ranch Prepack | 72162-2183 | ORAL | 5 mg in 1 1 | 12/11/2023 | |
| State of Florida DOH Central Pharmacy | 53808-1056 | ORAL | 1 mg in 1 1 | 1/19/2015 | |
| A-S Medication Solutions | 50090-0659 | ORAL | 10 mg in 1 1 | 2/28/2019 | |
| Northwind Pharmaceuticals, LLC | 51655-676 | ORAL | 5 mg in 1 1 | 3/19/2015 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| HYTRIN TABLET 5 mg | SIN11676P | TABLET | 5 mg | 9/21/2001 | |
| TERASIN TABLET 2 mg | SIN11600P | TABLET | 2 mg | 7/31/2001 | |
| HYTRIN TABLET 1 mg | SIN11674P | TABLET | 1 mg | 9/21/2001 | |
| HYTRIN TABLET 2 mg | SIN11675P | TABLET | 2 mg | 9/21/2001 | |
| APO-TERAZOSIN TABLET 2 mg | SIN12672P | TABLET | 2 mg | 9/21/2005 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Terazosin Hydrochloride Tablets | 国药准字H20010660 | 化学药品 | 片剂 | 4/13/2020 | |
| Terazosin Hydrochloride Tablets | 国药准字H20064420 | 化学药品 | 片剂 | 5/14/2020 | |
| Terazosin Hydrochloride Tablets | 国药准字H20094001 | 化学药品 | 片剂 | 9/30/2019 | |
| Terazosin Hydrochloride Tablets | 国药准字H20067067 | 化学药品 | 片剂 | 8/9/2021 | |
| Terazosin Hydrochloride Tablets | 国药准字H20010661 | 化学药品 | 片剂 | 4/13/2020 | |
| Terazosin Hydrochloride Tablets | 国药准字H20103431 | 化学药品 | 片剂 | 8/31/2020 | |
| Terazosin Hydrochloride Tablets | 国药准字H20083417 | 化学药品 | 片剂 | 1/18/2023 | |
| Terazosin Hydrochloride Tablets | 国药准字H20059992 | 化学药品 | 片剂 | 8/17/2020 | |
| Terazosin Hydrochloride Tablets | 国药准字H20058630 | 化学药品 | 片剂 | 5/14/2020 | |
| Terazosin Hydrochloride Tablets | 国药准字H20103323 | 化学药品 | 片剂 | 12/13/2019 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||